β-CCT, a selective BZ-ω1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice

Behavioural Pharmacology

Volumn 11, Issue 2, 2000, Pages 125-131

  Belzung, C ^a   Le Guisquet, A M ^a   Griebel, G ^b  

^a UFR Sciences et Techniques   (France)

^b SANOFI   (France)

Author keywords

Anxiety; Benzodiazepine; BZ 1 receptors; Elevated plus maze; Memory; Mouse; Passive avoidance; Radial arm maze; CCT

Indexed keywords

BENZODIAZEPINE RECEPTOR; BETA CARBOLINE 3 CARBOXYLIC ACID BUTYL ESTER; CHLORDIAZEPOXIDE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; RECEPTOR BLOCKING; TRANQUILIZING ACTIVITY;

EID: 0034022348     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200004000-00004     Document Type: Article

References (46)

1. Ågmo A, Belzung C (1998). The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. Neurophamacology 37:223-232.
2. Anglade F, Christin D, Marchaland C, Trouiller G, Baudouin C, Chapouthier G (1993). Analyse du comportement du rat dans la piscine de Morris: nouvelle méthodologie et application pharmacologique. Comptes Rend Acad Sci 316:603-606.
3. Barbée JG (1993). Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives. J Clin Psychiatry 54 (suppl):86-97.
4. Belzung C (1999). Measuring rodent exploratory behavior. In Handbook of Molecular-Genetic Techniques for Brain and Behavior Research (Techniques in the Behavioral Sciences, Vol. 13). Crusio WE, Gerlai RT (editors). Elsevier, Amsterdam, pp. 738-749.
5. Belzung C, Dubreuil D (1998). Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice. Behav Pharmacol 9:691-698.
6. Belzung C, Le Pape G (1994). Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol Behav 56:623-628.
7. Belzung C, Misslin R, Vogel E, Dodd RH, Chapouthier G (1987). Anxiogenic effects of methyl-β-carboline-3-carboxylate in a light/dark choice situation. Pharmacol Biochem Behav 28:29-33.
8. Beuzen A, Belzung C, Roullet P (1994). Drug effects in a radial maze designed for dissociation of cues used by mice. Pharmacol Biochem Behav 48:23-29.
9. Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu FR et al. (1982). Benzodiazepine antagonist RO 15-1788: neurological and behavioral effects. Psychopharmacology 78:8-18.
10. Cole SO (1990). Diazepam-induced impairment of a Go-NoGo successive discrimination. Behav Neural Biol 53:371-377.
11. 1 receptor subtype specific antagonist. Med Chem Res 5:710-718.
12. Crusio WE (1996). Gene-targeting studies: New methods, old problems - Commentary. Trends Neurosci 19:186-187.
13. Curran HV (1991). Benzodiazepines, memory and mood: a review. Psychopharmacology 105:1-8.
14. DeNoble VJ, Jones KW, Schaeffer CL, Bauerle LM (1990). 3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and phencyclidine produce a deficit of passive avoidance retention in rats. Eur J Pharmacol 175:197-202.
15. Gerlai R (1996a). Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype? Trends Neurosci 19:177-181.
16. Gerlai R (1996b). Molecular genetic analysis of mammalian behavior and brain processes: Caveats and perspectives. Semin Neurosci 8:153-161.
17. Gerlai R (1999). Targeting genes associated with mammalian behavior: past mistakes and future solutions. In Handbook of Molecular-Genetic Techniques for Brain and Behavior Research (Techniques in the Behavioral Sciences, Vol. 13). Crusio WE, Gerlai RT (editors). Elsevier, Amsterdam, pp. 364-375.
18. Griebel G, Sanger DJ, Perrault G (1996a). Further evidence for differences between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands in murine models of 'state' and 'trait' anxiety. Neuropharmacology 35:1081-1091.
19. Griebel G, Sanger DJ, Perrault G (1996b). The Mouse Defense Test Battery: Evaluation of the effects of non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Behav Pharmacol 7:560-572.
20. Griebel G, Sanger DJ, Perrault G (1996c). The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology 124:245-254.
21. Griebel G, Perrault G, Sanger DJ (1998). Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents. J Psychopharmacol 12:356-365.
22. Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ (1999). New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (ω) receptor subtypes. Psychopharmacology 146:205-213.
23. Griebel G, Perrault G, Sanger DJ (2000). Subtype-selective benzodiazepine receptor ligands. In Milestones in Drug Therapy -Anxiolytics, in press.
24. Hodges H, Green S (1986). Effects of chlordiazepoxide on cued radial maze performance in rats. Psychopharmacology 88:460-466.
25. Hunkeler W, Möhler H, Pieri L, Pole P, Bonetti EP, Cumin R et al. (1981). Selective antagonists of benzodiazepines. Nature 290:514-516.
26. Jensen LH, Stephens DN, Sarter M, Petersen EN (1987). Bidirectional effects of β-carboline and benzodiazepines on cognitive processes. Brain Res Bull 19:359-364.
27. Jones GH, Schneider C, Schneider HH, Seidler J, Cole BJ, Stephens DN (1994). Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: An analysis based on fractional receptor occupancies. Psychopharmacology 114:191-199.
28. Langer SZ, Arbilla S (1988). Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes. Pharmacol Biochem Behav 29:763-766.
29. Luddens H, Korpi ER, Seeburg PH (1995). GABA(A) benzodiazepine receptor heterogeneity: Neurophysiological implications. Neuropharmacology 34:245-254.
30. McNamara RK, Skelton RW (1992). Pharmacological dissociation between the spatial learning deficits produced by morphine and diazepam. Psychopharmacology 108:147-152.
31. McNaughton N, Morris RG (1987). Chlordiazepoxide, an anxiolytic benzodiazepine, impairs place navigation in rats. Behav Brain Res 24:39-46.
32. Nabeshima T, Tohyama K, Kameyama T (1990a). Effects of DM-9384, a pyrrolidone derivative, on alcohol-and chlordiazepoxide-induced amnesia in mice. Pharmacol Biochem Behav 36:233-236.
33. Nabeshima T, Tohyama K, Ichihara K, Kameyama T (1990b). Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system. J Pharmacol Exp Ther 255:789-794.
34. Nakamura-Palacios EM, Roelke CE (1997). Effects of acute or daily administration of diazepam on spatial learning and working memory. Drug Alcohol Depend 46:181-190.
35. Rocha BA, Scearce-Levie K, Lucas JJ, Hiroi N, Castanon N, Crabbe JC et al. (1998). Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393:132-137.
36. A receptor subtypes. Nature 401:796-800.
37. Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994). Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: Evidence for the functional significance of receptor subtypes. Neurosci Biobehav Rev 18:355-372.
38. 1 benzodiazepine receptor antagonist. Life Sci 35:2227-2236.
39. Sieghart W (1995). Structure and pharmacology of gamma-aminobutyric acid(A) receptor subtypes. Pharmacol Rev 47:181-234.
40. Stackmann RW, Walsh TJ (1992). Chlordiazepoxide-induced working memory impairments: site specificity and reversal by flumazenil (RO 15-1788). Behav Neural Biol 57:233-243.
41. Stephens DN, Voet B (1994). Differential effects of anxiolytic and non-anxiolytic benzodiazepine receptor ligands on performance of a differential reinforcement of low rate (DRL) schedule. Behav Pharmacol 5:4-14.
42. Stephens DN, Schneider HH, Kehr W, Andrews JS, Rettig KJ, Turski L et al. (1990). Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors. J Pharmacol Exp Ther 253:334-343.
43. Thiebot MH (1985). Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci Biobehav Rev 9:95-100.
44. Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986). Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 321:864-866.
45. Woods JH, Katz JL, Winger G (1992). Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151-347.
46. Zivkovic B, Perrault G, Sanger D (1992). Receptor subtype-selective drugs: a new generation of anxiolytics and hypnotics. In Target Receptors for Anxiolytics and Hypnotics: From Molecular Pharmacology to Therapeutics. Mendlewitz J, Racagni G (editors). Basel: Karger, pp. 55-73.